Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:48 am
GLP-1 agonists
Novo Nordisk
Eli Lilly
obesity
weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena
Thu, 06/13/24 - 11:03 am
Palatin
clinical trials
breatelanotide
obesity
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
Fierce Biotech
Wed, 06/12/24 - 11:16 am
Pfizer
Flagship Pioneering
ProFound Therapeutics
obesity
drug development
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market
BioSpace
Tue, 06/11/24 - 11:27 am
Syntis Bio
obesity
weight loss
SYNT-101
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters
Mon, 06/10/24 - 06:06 pm
Eli Lilly
Zepbound
Mounjaro
patients
obesity
diabetes
Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Medical Marketing and Media
Tue, 06/4/24 - 11:48 am
Novo Nordisk
Wegovy
weight loss
obesity
DTC advertising
Lilly wins NICE endorsement for tirzepatide in obesity—with a catch
Fierce Pharma
Tue, 06/4/24 - 11:38 am
Eli Lilly
UK
NICE
tirzepatide
obesity
type 2 diabetes
diabetes
Structure Therapeutics pill leads to competitive weight loss in obesity study
BioPharma Dive
Mon, 06/3/24 - 10:26 pm
Structure Therapeutics
obesity
weight loss
GSBR-1290
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
weight loss
obesity
drug shortages
Ro
CinCor’s ‘hub-and-spoke’ parent nabs new funding to build its next biotechs
BioPharma Dive
Thu, 05/30/24 - 11:10 am
CinRx Pharma
funding
obesity
IBS
gastroparesis
America's doctors need more obesity medicine training
Axios
Tue, 05/28/24 - 10:49 am
physicians
obesity
GLP-1 agonist
Wegovy
Wegovy users have fewer kidney-related health problems, analysis of Novo study finds
Reuters
Sun, 05/26/24 - 12:29 pm
Novo Nordisk
obesity
Wegovy
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Reuters
Fri, 05/24/24 - 11:12 am
Eli Lilly
obesity
Indiana
drug manufacturing
SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
BioPharma Dive
Wed, 05/22/24 - 11:24 am
SixPeaks
obesity
funding
AstraZeneca
GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData
BioSpace
Mon, 05/20/24 - 06:02 pm
GLP-1 agonist
weight loss
obesity
diabetes
Genetic profile may predict best response to weight-loss drug Wegovy
Reuters
Mon, 05/20/24 - 11:09 am
Novo Nordisk
Wegovy
genetics
obesity
weight loss
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes
Fierce Biotech
Thu, 05/9/24 - 11:48 am
Innovent
Eli Lilly
mazdutide
obesity
type 2 diabetes
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs
BioSpace
Thu, 05/9/24 - 11:43 am
Novo Nordisk
Metaphore
obesity
R&D
Decades-old law limits access to Wegovy for Medicaid beneficiaries
NPR
Wed, 05/8/24 - 11:06 pm
Novo Nordisk
Wegovy
obesity
Medicaid
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »